Development of a machine learning model to predict overall survival results from randomized clinical trials of patients with metastatic prostate cancer.

被引:0
|
作者
Sabbagh, Ali
Quigley, David Alan
Lillis, Nicholas
Zhang, Li
Friesner, Isabel D.
Bailey, Adina
Aggarwal, Rahul Raj
Chappidi, Meera Reddy
Singhal, Hari
Zhang, Ke
Greshock, Joel
Li, Jinhui
Yu, Margaret K.
Small, Eric J.
Hong, Julian C.
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Radiol & Biomed Imaging, San Francisco, CA 94143 USA
[3] Janssen Res & Dev, San Francisco, CA USA
[4] Janssen Res & Dev La Jolla, San Diego, CA USA
[5] Johnson & Johnson Innovat Med, Res & Dev, Raritan, NJ USA
[6] Johnson & Johnson Med China, Shanghai, Peoples R China
[7] Janssen Res & Dev LLC, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5065
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer.
    Kushnir, Igal
    Mallick, Ranjeeta
    Ong, Michael
    Canil, Christina
    Bosse, Dominick
    Koczka, Kim
    Reaume, M. Neil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites
    Tappero, Stefano
    Piccinelli, Mattia Luca
    Incesu, Reha-Baris
    Garcia, Cristina Cano
    Barletta, Francesco
    Morra, Simone
    Scheipner, Lukas
    Baudo, Andrea
    Tian, Zhe
    Parodi, Stefano
    Dell'Oglio, Paolo
    de Cobelli, Ottavio
    Graefen, Markus
    Chun, Felix K. H.
    Briganti, Alberto
    Longo, Nicola
    Ahyai, Sascha
    Carmignani, Luca
    Saad, Fred
    Shariat, Shahrokh F.
    Suardi, Nazaren
    Borghesi, Marco
    Terrone, Carlo
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 47 - 55.e2
  • [23] Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer
    Lohman, Elise A. J. de Savornin
    de Bitter, T. J. J.
    Hannink, G.
    Wietsma, M. F. T.
    Vink-Borger, E.
    Nagtegaal, I. D.
    Hugh, T. J.
    Gill, A. J.
    Bhimani, N.
    Ahadi, M. Seyed
    van der Post, R. S.
    de Reuver, Philip R.
    ANNALS OF SURGERY, 2023, 277 (04) : e856 - e863
  • [24] Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database
    Fay, Andre P.
    McKay, Rana R.
    Lin, Xun
    Sirnantov, Ronit
    Choueiri, Toni K.
    JOURNAL OF GLOBAL ONCOLOGY, 2018, 4 : 1 - 14
  • [25] Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
    Joanne L. Blum
    Joseph Kohles
    Edward McKenna
    Nana Scotto
    Sylvia Hu
    Dawn Odom
    James A. Kaye
    Stefan Glück
    Breast Cancer Research and Treatment, 2011, 125 : 431 - 439
  • [26] Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials
    Blum, Joanne L.
    Kohles, Joseph
    McKenna, Edward
    Scotto, Nana
    Hu, Sylvia
    Odom, Dawn
    Kaye, James A.
    Glueck, Stefan
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 431 - 439
  • [27] Overall Survival Prediction Via an Interpretable Machine Learning Model for Patients with Oropharyngeal Cancer
    Pan, X.
    Feng, T.
    Qi, X.
    Liu, C.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [28] IMPROVED SURVIVAL IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) TREATED ON CLINICAL TRIALS
    Pezaro, C.
    Omlin, A. G.
    Mukherji, D.
    Sandhu, S.
    Bianchini, D.
    Cassidy, A. Mulick
    Maier, G.
    Olmos, D.
    Attard, G.
    de Bono, J. S.
    ANNALS OF ONCOLOGY, 2012, 23 : 298 - 298
  • [29] Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naive Prostate Cancer in Japanese Men
    Nakagawa, Ryunosuke
    Iwamoto, Hiroaki
    Makino, Tomoyuki
    Naito, Renato
    Kadomoto, Suguru
    Akatani, Norihito
    Yaegashi, Hiroshi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Kadono, Yoshifumi
    Takamatsu, Atsushi
    Yoshida, Kotaro
    Mizokami, Atsushi
    CANCERS, 2022, 14 (19)
  • [30] Survival in Black and non-Black patients with metastatic prostate cancer.
    Cheranda, Nina
    Luo, Suhong
    Sanfilippo, Kristen Marie
    Eisen, Seth A.
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41